Bondok Rasha S, El Sharnouby Noha M, Eid Hala E, Abd Elmaksoud Ahmed M
Department of Anaesthesiology and Intensive Care, Ain-Shams University Hospitals, Cairo, Egypt.
Crit Care Med. 2006 Nov;34(11):2781-3. doi: 10.1097/01.CCM.0000242156.15757.70.
Intractable hyperemesis gravidarum remains a serious cause of morbidity among pregnant women. If not controlled, hyperemesis gravidarum can lead to severe disability, electrolyte and acid base imbalance, and even various organ system dysfunctions. From the successful use of steroids for chemotherapy-induced emesis, corticosteroids might prove useful in hyperemesis gravidarum. The purpose of this study was to compare the efficacy of pulsed hydrocortisone therapy with that of metoclopramide for the management of intractable hyperemesis gravidarum.
Prospective, double-blind study.
Intensive care unit of Ain Shams University Maternity Hospital.
Forty patients aged 19-34 yrs having a normal appearing intrauterine pregnancy, of < or =16 wks gestation, admitted to the intensive care unit with intractable hyperemesis meeting the study criteria.
Patients were randomly assigned to receive either intravenous hydrocortisone 300 mg as a daily dose or intravenous metoclopramide 10 mg 3 times daily. After 3 days the hydrocortisone was tapered completely during the course of 1 wk, whereas the metoclopramide was continued without change for 1 wk. Patients were followed up daily during the therapy course and for 2 wks following intensive care unit discharge.
There was a significant reduction in vomiting episodes in the hydrocortisone group compared with the metoclopramide group (p < .0001). Within-patient analyses showed a significant reduction in mean vomiting episodes in the hydrocortisone group within the first 3 days (p < .0001). No patients from the hydrocortisone group but six of the patients receiving metoclopramide were readmitted for intractable vomiting within 1 wk from discharge. Five of them showed improvement on intravenous hydrocortisone therapy.
A short course of hydrocortisone is an effective treatment for intractable hyperemesis gravidarum.
难治性妊娠剧吐仍是孕妇发病的一个严重原因。若不加以控制,妊娠剧吐可导致严重残疾、电解质及酸碱失衡,甚至多器官系统功能障碍。鉴于类固醇已成功用于治疗化疗引起的呕吐,皮质类固醇可能对妊娠剧吐有效。本研究的目的是比较脉冲式氢化可的松疗法与甲氧氯普胺治疗难治性妊娠剧吐的疗效。
前瞻性双盲研究。
艾因夏姆斯大学妇产医院重症监护病房。
40名年龄在19 - 34岁之间、宫内妊娠外观正常、妊娠≤16周、因符合研究标准的难治性妊娠剧吐入住重症监护病房的患者。
患者被随机分配接受每日静脉注射300 mg氢化可的松或每日3次静脉注射10 mg甲氧氯普胺。3天后,氢化可的松在1周内完全减量,而甲氧氯普胺持续不变地使用1周。在治疗过程中每天对患者进行随访,并在重症监护病房出院后随访2周。
与甲氧氯普胺组相比,氢化可的松组的呕吐发作次数显著减少(p < .0001)。患者内分析显示,氢化可的松组在前3天内平均呕吐发作次数显著减少(p < .0001)。氢化可的松组无患者因难治性呕吐在出院后1周内再次入院,但接受甲氧氯普胺治疗的患者中有6例再次入院。其中5例在接受静脉注射氢化可的松治疗后病情好转。
短期使用氢化可的松是治疗难治性妊娠剧吐的有效方法。